New Stent Design Eases Severe Chest Pain From Microvascular Disease
The stent significantly improved chest pain, quality of life, and coronary microvascular function in patients in a phase 2 clinical trial.
Read MoreThe stent significantly improved chest pain, quality of life, and coronary microvascular function in patients in a phase 2 clinical trial.
Read MoreThe single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.
Read MoreThe acquisition will complement Boston Scientific’s electrophysiology portfolio with an FDA-cleared solution to advance the treatment of complex atrial fibrillation.
Read MoreResearchers have developed an optimized electrophysiological model showing that heart defibrillation can be achieved with much lower energy than current methods used.
Read MoreTrue North ITG’s CEO Matt Murren discusses strategies for cardiology groups to overcome IT and budget challenges, from optimizing infrastructure to enhancing security and reducing costs.
Read More